Editorial · Longform
Perspectives
Op-ed-style writing on contributorship, AI in publishing, evaluation reform, persistent identifiers, and the shape of the research-administration vocabulary.
Perspectives is not yet a separately-tagged section — showing CASRAI's most recent editorial coverage from the full news index.
CMU’s $240M Deep Tech Venture-Ready Program
Carnegie Mellon’s Swartz Center for Entrepreneurship launched a Deep Tech Venture-Ready Program in April 2026 backed by $240M in soft-circled capital from 30 VC and corporate partners — a distinct model from a university venture fund, worth understanding precisely because the capital is prospective, not committed.
FDA’s 2026 Unified Agenda: Trial Reform Docket
FDA’s July 2026 Unified Agenda lists a dozen new proposed rules on clinical trials, Phase 1 IND, DTC ads, and CRL disclosure beyond the IND pilot.
HHS OIG RFI: AKS Safe Harbors for Trial Pay
HHS OIG is asking whether the Anti-Kickback Statute needs a new safe harbor for paying clinical trial participants. Comments on the RFI are due August 24, 2026.
Will Paying Reviewers Ease the Peer Review Crisis?
Advances in Psychology has paid $100/review since 2022; NIH may reward journals that pay reviewers ~$50/hr and publish their comments.
DORA, CoARA Host Asia-Pacific RRA Workshop
DORA, FORCE11, CoARA and ALLEA convened funders, publishers and universities in Singapore to compare Asia-Pacific approaches to research-assessment reform.
ANID’s Open Access Mandate Goes Full-Scale in 2026
Chile’s ANID is extending its 2022 Open Access Policy across every instrument it funds in 2026, backed by a new EspacioCiencia repository service and renewed InES Ciencia Abierta capacity funding. Here’s what the mandate actually requires.
PMAC Opens: What It Means for University TTOs
The UPC’s Patent Mediation and Arbitration Centre opened in phases from May 12, 2026 — what it means for university patent-licensing and enforcement strategy.
FDA’s Elsa 4.0 and HALO: Sponsor Impact
FDA shipped Elsa 4.0 and the HALO data platform in May 2026 — an internal AI upgrade, not a sponsor-facing one. Here is what changed and what did not.
